OpenAI has expanded ChatGPT Health to everyone in the United States, widening access to its health-focused assistant at a time when the company is also facing serious legal pressure. The broader launch marks a significant step for OpenAI's consumer AI tools, but it also puts renewed attention on how people may use ChatGPT for medical questions.
The timing is especially notable because OpenAI has reportedly been hit with two lawsuits in the past three months over claims that ChatGPT provided dangerous medical advice. According to the description of the report, those cases allege harm and, in some instances, fatal outcomes tied to advice generated by the chatbot.
That combination of wider availability and growing legal scrutiny is likely to intensify debate over AI in health settings. Supporters of AI assistants argue that these tools can make information easier to access, while critics warn that medical guidance from a chatbot can be misunderstood, incomplete, or unsafe when users treat it like professional care.
With ChatGPT Health now rolling out nationwide in the US, OpenAI's health assistant is entering a more visible phase just as questions about safety, accountability, and oversight become harder to ignore. The expansion shows OpenAI is continuing to push forward on health-related features even as courts and the public examine the risks more closely.
